These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 37375975)

  • 1. Overcoming the Challenges of Phytochemicals in Triple Negative Breast Cancer Therapy: The Path Forward.
    Alaouna M; Penny C; Hull R; Molefi T; Chauke-Malinga N; Khanyile R; Makgoka M; Bida M; Dlamini Z
    Plants (Basel); 2023 Jun; 12(12):. PubMed ID: 37375975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells.
    Bilir B; Kucuk O; Moreno CS
    J Transl Med; 2013 Nov; 11():280. PubMed ID: 24188694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Tumor Microenvironment: Emerging target of therapeutic phytochemicals.
    Malla RR; Deepak K; Merchant N; Dasari VR
    Phytomedicine; 2020 Apr; 70():153227. PubMed ID: 32339885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer.
    Farghadani R; Naidu R
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling.
    Shetti D; Zhang B; Fan C; Mo C; Lee BH; Wei K
    Cells; 2019 Aug; 8(8):. PubMed ID: 31416135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Triple-Negative Breast Cancer by the Phytopolyphenol Carnosol: ROS-Dependent Mechanisms.
    Alsamri H; Al Dhaheri Y; Iratni R
    Antioxidants (Basel); 2023 Jun; 12(7):. PubMed ID: 37507889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential therapeutic targets of triple-negative breast cancer based on its intrinsic subtype.
    Shao F; Sun H; Deng CX
    Oncotarget; 2017 Sep; 8(42):73329-73344. PubMed ID: 29069872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sesamol inhibits proliferation, migration and invasion of triple negative breast cancer via inactivating Wnt/β-catenin signaling.
    Ma X; Hu X; Zhu Y; Jin H; Hu G; Ding L; Ning S
    Biochem Pharmacol; 2022 Dec; 206():115299. PubMed ID: 36244446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential of Natural Products in the Treatment of Triple-negative Breast Cancer.
    Ke DYJ; El-Sahli S; Wang L
    Curr Cancer Drug Targets; 2022; 22(5):388-403. PubMed ID: 34970954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research advances and new challenges in overcoming triple-negative breast cancer.
    Zong Y; Pegram M
    Cancer Drug Resist; 2021; 4(3):517-542. PubMed ID: 34888495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer.
    Liu S; Wang Z; Liu Z; Shi S; Zhang Z; Zhang J; Lin H
    J Mol Cell Biol; 2018 Aug; 10(4):302-315. PubMed ID: 30053090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
    Fatima I; El-Ayachi I; Taotao L; Lillo MA; Krutilina RI; Seagroves TN; Radaszkiewicz TW; Hutnan M; Bryja V; Krum SA; Rivas F; Miranda-Carboni GA
    PLoS One; 2017; 12(12):e0189864. PubMed ID: 29281678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation.
    Shome R; Ghosh SS
    Cell Oncol (Dordr); 2021 Apr; 44(2):405-422. PubMed ID: 33398673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
    Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
    J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico molecular docking and physicochemical property studies on effective phytochemicals targeting GPR116 for breast cancer treatment.
    Muthiah I; Rajendran K; Dhanaraj P
    Mol Cell Biochem; 2021 Feb; 476(2):883-896. PubMed ID: 33106912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis.
    Zhang H; Wang J; Yin Y; Meng Q; Lyu Y
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33443534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "Big Five" Phytochemicals Targeting Cancer Stem Cells: Curcumin, EGCG, Sulforaphane, Resveratrol and Genistein.
    Naujokat C; McKee DL
    Curr Med Chem; 2021; 28(22):4321-4342. PubMed ID: 32107991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oncogenic kinase NEK2 regulates an RBFOX2-dependent pro-mesenchymal splicing program in triple-negative breast cancer cells.
    Naro C; De Musso M; Delle Monache F; Panzeri V; de la Grange P; Sette C
    J Exp Clin Cancer Res; 2021 Dec; 40(1):397. PubMed ID: 34930366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis.
    Paul A; Gunewardena S; Stecklein SR; Saha B; Parelkar N; Danley M; Rajendran G; Home P; Ray S; Jokar I; Vielhauer GA; Jensen RA; Tawfik O; Paul S
    Cell Death Differ; 2014 Sep; 21(9):1469-81. PubMed ID: 24786829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinase inhibitors for precision therapy of triple-negative breast cancer: Progress, challenges, and new perspectives on targeting this heterogeneous disease.
    Mehlich D; Marusiak AA
    Cancer Lett; 2022 Oct; 547():215775. PubMed ID: 35667515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.